Potential drug-drug interactions in internal medicine wards in hospital setting in Pakistan

被引:49
作者
Ismail, Mohammad [1 ]
Iqbal, Zafar [1 ]
Khattak, Muhammad Bilal [2 ]
Khan, Muhammad Imran [2 ]
Arsalan, Hassan [3 ]
Javaid, Arshad [4 ]
Gul, Qamar [5 ]
Khan, Faramoz [6 ]
机构
[1] Univ Peshawar, Dept Pharm, Peshawar, Khyber Pakhtunk, Pakistan
[2] Ayub Teaching Hosp, Ayub Med Coll, Abbottabad, Khyber Pakhtunk, Pakistan
[3] Sarhad Univ Sci & Informat Technol, Dept Pharm, Peshawar, Pakistan
[4] LRH, PGMI, Peshawar, Pakistan
[5] Univ Malakand, Dept Pharm, Chakdara, Khyber Pakhtunk, Pakistan
[6] Khyber Teaching Hosp, Med Unit B, Peshawar, Pakistan
关键词
Adverse drug interaction; Clinical pharmacy; Drug related problem; Pakistan; Potential drug-drug interaction; Prescriptions screening;
D O I
10.1007/s11096-013-9764-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background Multiple drugs therapies may be the potential source of drug-drug interactions that can result in alteration of therapeutic response and/or increase untoward effects of many drugs. Objective To identify the frequency and levels of potential drug-drug interactions (pDDIs) in internal medicine wards and their association with patients' age, gender, length of hospital stay and number of prescribed medications; and to describe management of frequently identified major or moderate pDDIs. Setting Internal medicine wards of two major tertiary care hospitals of Khyber Pakhtunkhwa, Pakistan. Method Micromedex Drug-Reax system was used to screen patient's profiles for pDDIs. Logistic regression was applied to determine the odds ratio for specific risk factors of pDDIs i.e., age, gender, hospital-stay and number of medications. Main outcome measure Overall prevalence and prevalence of contraindicated, major, moderate and minor pDDIs; levels of pDDIs; frequently identified major or moderate interactions; and odds ratios for risk factors. Results Total, 188 interacting drug-combinations were identified that contributed to 675 pDDIs. Of 400 patients, 52.8 % patients were presented with at least one pDDI (overall prevalence), 21.3 % with at least one major-pDDI, and 44.3 % with at least one moderate-pDDI. Of 675 pDDIs, most were of moderate (63.6 %) or major severity (23 %); good (61.2 %) or fair (25.5 %) type of scientific evidence; and delayed onset (50.2 %). Most frequently identified major or moderate interactions resulted in 45.3 % of all pDDIs. Their potential adverse outcomes included hepatotoxicity, bleeding, ototoxicity, nephrotoxicity, hypoglycemia, hyperglycemia, risk of thrombosis, hypotension, cardiac arrhythmias and reduction in therapeutic-effectiveness. There was significant association of the occurrence of pDDIs with patients' age of 60 years or more (OR = 2.1; 95 % CI = 1.3-3.3; p = 0.003), hospital stay of 6 days or longer (OR = 2.6; 95 % CI = 1.5-4.5; p = 0.001), and seven or more number of prescribed medications (OR = 5.9; 95 % CI = 3.6-9.6; p < 0.001). Conclusion The present study has recorded a high prevalence of pDDIs in internal medicine wards. Patients with old age, longer hospital stay and increased number of prescribed medications were at higher risk.
引用
收藏
页码:455 / 462
页数:8
相关论文
共 24 条
  • [11] Ibanez A, 2008, Farm Hosp, V32, P293
  • [12] Potential Drug-Drug Interactions in Psychiatric Ward of a Tertiary Care Hospital: Prevalence, Levels and Association with Risk Factors
    Ismail, Mohammad
    Iqbal, Zafar
    Khattak, Muhammad Bilal
    Javaid, Arshad
    Khan, Muhammad Imran
    Khan, Tahir Mehmood
    Asim, Syed Muhammad
    [J]. TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2012, 11 (02) : 289 - 296
  • [13] Ismail M, 2010, HEALTHMED, V4, P1044
  • [14] Drug-drug interactions among elderly patients hospitalized for drug toxicity
    Juurlink, DN
    Mamdani, M
    Kopp, A
    Laupacis, A
    Redelmeier, DA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (13): : 1652 - 1658
  • [15] Drug related critical incidents
    Khan, FA
    Hoda, MQ
    [J]. ANAESTHESIA, 2005, 60 (01) : 48 - 52
  • [16] Krähenbühl-Melcher A, 2007, DRUG SAFETY, V30, P379
  • [17] Nishtar Sania, 2006, J Pak Med Assoc, V56, pS100
  • [18] Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients
    Pirmohamed, M
    James, S
    Meakin, S
    Green, C
    Scott, AK
    Walley, TJ
    Farrar, K
    Park, BK
    Breckenridge, AM
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2004, 329 (7456): : 15 - 19
  • [19] Potential drug interactions and duplicate prescriptions among cancer patients
    Riechelmann, Rachel P.
    Tannock, Ian F.
    Wang, Lisa
    Saad, Everardo D.
    Taback, Nathan A.
    Krzyzanowska, Monika K.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (08): : 592 - 600
  • [20] Potential for drug interactions in hospitalized cancer patients
    Riechelmann, RP
    Moreira, F
    Smaletz, O
    Saad, ED
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 56 (03) : 286 - 290